Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy

Infezioni in Medicina

Volumn 17, Issue 1, 2009, Pages 35-37

  Lanzafame, Massimiliano ^a   Ferrari, Sergio ^a   Lattuada, Emanuela ^a   Corsini, Fabiana ^a   Deganello, Roberto ^a   Vento, Sandro ^b   Concia, Ercole ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Osp Civ Annunziata   (Italy)

Author keywords

Depression; HIV infection; Mirtazapine; Progressive multifocal leukoencephalopathy

Indexed keywords

LAMIVUDINE; MIRTAZAPINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DRUG EFFECT; GAIT DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV-1; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MENINGITIS, CRYPTOCOCCAL; MIANSERIN; VIRUS INTERNALIZATION;

EID: 65649103403     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Verma S. Cikurel K. Koralnik I. J. et al. Mirtaza-pine in progressive multifocal leukoencephalopathy associated polycytemia vera. J. Infect. Dis. 196, 709-711, 2007.
2. Vulliemoz S. Lurati-Ruiz F. Borruat F. X. et al. Favourable outcome of progressive multifocal leu-coencephalopathy in two patients with dermato-myositis. J. Neurol. Neurosurg. Psychiatry 77, 1079-1082, 2006.
3. Elphick G. F. Querbes W. Jordan J. A. et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306, 1380-1383, 2004.
4. Albrecht H. Hoffmann C. Degen O. et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12, 1149-1154, 1998.
5. Berenguer J. Miralles P. Arrizabalaga J. et al. GESI-DA 11/99 Study Group. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin. Infect. Dis. 36, 1047-1052, 2003.
6. De Luca A. Giancola M. L. Ammassari A. et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J. Infect. Dis. 182, 1077-1083, 2000.
7. Gasnault J. Kousignian P. Kaharaman M. et al. Cidofovir in AIDS- associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J. Neurovirol. 7, 375-381, 2001.
8. Focosi D. Fazzi R. Montanaro D. Emdin M. Petrini M. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res. 74, 156-158, 2006.
9. Owczarczyk K. Hilker R. Brunn A. Hallek M. Rubbert A. Progressive multifocal leukoencephalopathy in a patient with sarcoidosis, successful treatment with cidofovir and mirtazapine. Rheumatology (Oxford) 46, 888-890, 2007.